Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Awan, Farrukh ORCID: 0000-0003-1813-9812, Jaeger, Ulrich, Rifkin, Robert, Thirman, Michael J., Byrd, John C., Hallek, Michael, Stromatt, Scott and Pagel, John M. (2012). Phase 1b Study of TRU-016, an Anti-CD37 SMIP (TM) Protein, in Combination with Bendamustine Vs Bendamustine Alone in Relapsed Chronic Lymphocytic Leukemia. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Gotlib, Jason, Kluin-Nelemans, Hanneke C., George, Tracy I., Akin, Cem, Sotlar, Karl, Hermine, Olivier, Awan, Farrukh ORCID: 0000-0003-1813-9812, Hexner, Elizabeth ORCID: 0000-0002-1125-4060, Mauro, Michael J., Morariu, Rodica, Squier, Margaret, Villeneuve, Matthieu, Emery-Salbert, Fabienne, Hartmann, Karin, Horny, Hans-Peter, Valent, Peter and Reiter, Andreas (2012). KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis: Results of a Planned Interim Analysis of the Global CPKC412D2201 Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Gotlib, Jason, Kluin-Nelemans, Hanneke C., George, Tracy I., Akin, Cem, Sotlar, Karl, Hermine, Olivier, Awan, Farrukh ORCID: 0000-0003-1813-9812, Hexner, Elizabeth O., Mauro, Michael, Sternberg, David, Villeneuve, Matthieu, Emery-Salbert, Fabienne, Stanek, Eric, Hartmann, Karin, Horny, Hans-Peter, Valent, Peter and Reiter, Andreas (2014). Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Robak, Tadeusz, Hellman, Andrzej, Loscertales, Javier, Lech-Maranda, Ewa ORCID: 0000-0001-9592-0851, Pagel, John M., Mato, Anthony R., Byrd, John C., Awan, Farrukh ORCID: 0000-0003-1813-9812, Hebart, Holger, Garcia-Marco, Jose A., Hill, Brian T., Hallek, Michael, Stromatt, Scott and Kloczko, Janusz (2014). Phase 2 Study of Otlertuzumab (TRU-016), an Anti-CD37 ADAPTIR (TM) Protein, in Combination with Bendamustine Vs Bendamustine Alone in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL) - Updated Results. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Fri Mar 29 13:35:21 2024 CET.